WHO @ Global Hepatitis Summit 2025

The 19^th Global Hepatitis Summit (GHS 2025), a 50-year legacy of the International Symposium on Viral Hepatitis and Liver Disease, will take place from 18 to 21 March 2025 in Los Angeles, United States of America.

GHS 2025 will feature the latest developments in viral hepatitis along 3 distinct tracks of basic/translational, clinical, and public health. 2025 has been designated by WHO as a milestone year to assess progress towards the 2030 goals to eliminate hepatitis B and C. Accordingly, GHS 2025 will be taking stock of progress to date while looking ahead towards research, clinical care, and public health interventions needed to eliminate hepatitis.

GHS 2025 will be as much a networking event as a cutting-edge research conference, featuring dedicated tracks for health practitioners and inspiring workshops for those working in the liver and hepatitis space, where renown speakers will highlight the most exciting recent results in the field and provide perspectives for research and patient management.

WHO will participate in several key sessions and side events at the summit to inform on progress towards elimination, and to share the latest scientific developments for preventing and treating viral hepatitis.

Table of Contents

Plenary sessions

A focus on where we are at Plenary session 1 Tuesday, 18 March, 17:00-18:00 (UCT-8)	Global progress on hepatitis B, C, and D elimination + Q&A Meg Doherty, Director, Global HIV, Hepatitis and STIs Programmes, WHO
State of the art: report card on drug development for HBV: lessons learned and the path forward Plenary session 2 Wednesday, 19 March, 10:30-12:00 (UCT-8)	Introductory talk: current & future therapies from a global perspective (challenges & barriers) Olufunmilayo (Funmi) Lesi, Team Lead, Global HIV, Hepatitis and STIs Programmes, WHO
Pathways towards hepatitis elimination Public health parallel session 6 Thursday, 21 March, 15:30-17:00 (UCT-8)	WHO progress, and next steps toward hepatitis elimination Olufunmilayo (Funmi) Lesi

Side meetings and workshop

Workshop on Development of Long-Acting Treatments for Persons with Hepatitis B
Tuesday, 18 March 2025, 07:30-12:30 (UCT-8) Los Angeles, United States of America

Public health and medical imperative – Session 1

Global public health significance
Olufunmilayo (Funmi) Lesi

Abbott Scientific Symposium. Together Towards a Hepatitis-free Future: Scaling-up Hepatitis B Rapid Testing in Antenatal Care
Wednesday, 19 March 2025, 12:00-13:30 (UCT-8) Los Angeles, United States of America

WHO Strategy and guidance for the elimination of mother-to-child transmission of hepatitis B
Niklas Luhmann, Technical Officer, Global HIV, Hepatitis and STIs Programmes, WHO

link